What's Happening?
A new U.S. Disease Tracker project, a collaboration between Johns Hopkins University and public health organizations, is under development to enhance the accessibility and understanding of information regarding vaccine-preventable diseases. This tool
is designed to provide data by state, smaller geographic areas, and age groups, making it easier for families to track disease spread. The project aims to complement the CDC’s National Notifiable Diseases Surveillance System by collecting standardized public health data reported weekly by participating jurisdictions. Currently, the tracker lists diseases such as measles, pertussis (whooping cough), invasive meningococcal disease, hepatitis A, acute hepatitis B, perinatal hepatitis B, mumps, mpox, varicella, and influenza-associated pediatric mortality. Data submission to the tracker is voluntary, and it collects only aggregate information to minimize the risk of identifying individuals. The data is not yet publicly available, and health officials advise continued reliance on state health departments, pediatricians, and the CDC for current vaccination and disease information until the public dashboard is launched.
Why It's Important?
This initiative is particularly significant for addressing existing vaccination disparities within the U.S., especially among Black Americans. According to CDC data, vaccination coverage in 2023 was generally lower among Black and Hispanic adults compared to white adults for several recommended vaccines. For instance, during the 2021-22 flu season, only 42% of Black adults received a flu vaccine, compared to 54% of white adults, contributing to nearly 80% higher flu hospitalization rates for Black adults from 2009 through 2022. Older Black adults also show lower rates of pneumococcal vaccination. By providing more granular and accessible data, the U.S. Disease Tracker could empower families, particularly those in underserved communities, to make informed decisions about vaccinations and disease prevention. This improved transparency could help public health efforts target areas with lower vaccination rates and higher disease prevalence, ultimately working to reduce health disparities and prevent outbreaks.
What's Next?
The U.S. Disease Tracker project is currently in development, and its data is not yet public. The immediate next step involves the continued development and eventual public launch of the dashboard. Once available, families and healthcare providers will have an additional resource to monitor vaccine-preventable diseases. In the interim, individuals are advised to continue utilizing existing resources such as the CDC, state or local health departments, pediatricians, and primary care providers for current vaccination recommendations and disease information. The project's success will depend on the voluntary data submission from participating jurisdictions and its ability to effectively communicate complex public health information to the general public. The long-term goal is to provide a user-friendly tool that complements national surveillance systems and supports proactive public health interventions.
Beyond the Headlines
The development of the U.S. Disease Tracker highlights a broader societal need for transparent and accessible public health data, especially in an era where vaccine hesitancy and misinformation can undermine community immunity. The project's focus on disaggregated data by race, ethnicity, and geographic area implicitly acknowledges the systemic inequities in healthcare access and outcomes. By making this information more readily available, the tracker could foster greater public engagement and accountability in vaccination efforts. Furthermore, the emphasis on complementing existing CDC systems rather than replacing them suggests a strategic approach to data integration and public health communication. This initiative could serve as a model for how technology and data science can be leveraged to address public health challenges, promote health equity, and build trust in public health institutions, provided the data is presented clearly and contextually to avoid misinterpretation.
